标题
Treatment options for lysosomal storage disorders: developing insights
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 13, Issue 16, Pages 2281-2299
出版商
Informa Healthcare
发表日期
2012-09-27
DOI
10.1517/14656566.2012.729039
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Therapy for Lysosomal Storage Diseases (LSDs) in Large Animal Models
- (2013) M. Haskins ILAR JOURNAL
- Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases
- (2012) Rosella Tomanin et al. ACTA PAEDIATRICA
- Velaglucerase Alfa for the Management of Type 1 Gaucher Disease
- (2012) Jennifer L. Morris CLINICAL THERAPEUTICS
- Structure–Activity Relationship of Novel Menaquinone-4 Analogues: Modification of the Side Chain Affects their Biological Activities
- (2012) Yoshitomo Suhara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic chaperone effect of N-Octyl 4-Epi-β-valienamine on murine GM1-gangliosidosis
- (2012) Yoshiyuki Suzuki et al. MOLECULAR GENETICS AND METABOLISM
- Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice
- (2012) Elfrida R Benjamin et al. MOLECULAR THERAPY
- Pharmacological chaperone therapy for Fabry disease
- (2012) Satoshi ISHII PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Newborn screening for lysosomal storage disorders
- (2011) Kimitoshi Nakamura et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Genistein in Sanfilippo disease: A randomized controlled crossover trial
- (2011) Jessica de Ruijter et al. ANNALS OF NEUROLOGY
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options
- (2011) E. Oussoren et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein
- (2011) Jeff Zhiqiang Lu et al. BIOTECHNOLOGY AND BIOENGINEERING
- Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease
- (2011) A. Zimran et al. BLOOD
- A mutation in SCARB2 is a modifier in gaucher disease
- (2011) Arash Velayati et al. HUMAN MUTATION
- Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease
- (2011) Caterina Porto et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Cysteamine therapy: a treatment for cystinosis, not a cure
- (2011) Stephanie Cherqui KIDNEY INTERNATIONAL
- Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients
- (2011) Chinmoy Sarkar et al. MOLECULAR GENETICS AND METABOLISM
- Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form — No positive effects after 2-years of miglustat therapy
- (2011) Anna Tylki-Szymańska et al. MOLECULAR GENETICS AND METABOLISM
- β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease
- (2011) Dwight D. Koeberl et al. MOLECULAR GENETICS AND METABOLISM
- Neural Stem Cell Transplantation as a Therapeutic Approach for Treating Lysosomal Storage Diseases
- (2011) Lamya S. Shihabuddin et al. Neurotherapeutics
- Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis
- (2010) Daisuke Tsuji et al. ANNALS OF NEUROLOGY
- A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1
- (2010) E. Lukina et al. BLOOD
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)
- (2010) J. Tolar et al. BLOOD
- Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II
- (2010) A Friso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators
- (2010) Juan J. Marugan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- Hematopoietic bone marrow cells participate in endothelial, but not epithelial or mesenchymal cell renewal in adult rats
- (2010) Kathrin I. Odörfer et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs
- (2010) Etty Osher et al. MOLECULAR GENETICS AND METABOLISM
- A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease
- (2010) Ans T. van der Ploeg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current International Perspectives on Hematopoietic Stem Cell Transplantation for Inherited Metabolic Disorders
- (2010) Jaap J. Boelens et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease
- (2010) Marcelina Malinowska et al. PLoS One
- Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders
- (2010) Xing-Li Meng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York
- (2009) Patricia K Duffner et al. GENETICS IN MEDICINE
- Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidase
- (2009) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase
- (2009) John J. Flanagan et al. HUMAN MUTATION
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice
- (2009) Marcelina Malinowska et al. MOLECULAR GENETICS AND METABOLISM
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease
- (2009) Yunxiang Zhu et al. MOLECULAR THERAPY
- The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease
- (2009) Richie Khanna et al. MOLECULAR THERAPY
- Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
- (2009) Paul Saftig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Newborn Screening for Krabbe Disease: the New York State Model
- (2009) Patricia K. Duffner et al. PEDIATRIC NEUROLOGY
- Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression
- (2008) Maria-Veronica Munoz-Rojas et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
- (2008) Jin-Song Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann–Pick C1 disease — Lysosomal storage disorders caused by defects of non-lysosomal proteins
- (2008) Thomas Dierks et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular and cellular basis of lysosomal transmembrane protein dysfunction
- (2008) Raquel Ruivo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Sorting of lysosomal proteins
- (2008) Thomas Braulke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Lysosomal disorders: From storage to cellular damage
- (2008) Andrea Ballabio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Clinical Outcome of Hurler Syndrome after Stem Cell Transplantation
- (2008) Mieke Aldenhoven et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients
- (2008) Ewa Piotrowska et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNA
- (2008) Stefan Worgall et al. HUMAN GENE THERAPY
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started